Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elena Milkina"'
Autor:
Igor Manzhulo, Olga Manzhulo, Anna Tyrtyshnaia, Arina Ponomarenko, Sophia Konovalova, Ekaterina Ermolenko, Elena Milkina, Anna Starinets
Publikováno v:
Brain Sciences, Vol 11, Iss 12, p 1561 (2021)
The present study demonstrates that synaptamide (N-docosahexaenoylethanolamine), an endogenous metabolite of docosahexaenoic acid, when administered subcutaneously (4 mg/kg/day, 14 days), exhibits analgesic activity and promotes cognitive recovery in
Externí odkaz:
https://doaj.org/article/74213d87f4f8440daa32c166d7208610
Autor:
Sophia Konovalova, Ekaterina V. Ermolenko, Arina Ponomarenko, Igor Manzhulo, Elena Milkina, Olga Manzhulo, Anna Tyrtyshnaia, Anna Starinets
Publikováno v:
Brain Sciences; Volume 11; Issue 12; Pages: 1561
Brain Sciences
Brain Sciences, Vol 11, Iss 1561, p 1561 (2021)
Brain Sciences
Brain Sciences, Vol 11, Iss 1561, p 1561 (2021)
The present study demonstrates that synaptamide (N-docosahexaenoylethanolamine), an endogenous metabolite of docosahexaenoic acid, when administered subcutaneously (4 mg/kg/day, 14 days), exhibits analgesic activity and promotes cognitive recovery in
Autor:
Andrey Bryukhovetskiy, Irina Lyakhova, Maxim Khotimchenko, Yuri Khotimchenko, Igor Kudryavtsev, Maxim E. Zhidkov, Polina Mischenko, Elena Milkina, Igor Bryukhovetskiy, Alexander Polevshchikov, Sergei Zaitsev
Publikováno v:
Oncology Letters
Glioblastoma multiforme is an invasive malignant glial brain tumor with a poor prognosis for patients. The primary reasons that lead to the development of treatment resistance are associated with tumor cells infiltrating the brain parenchyma and the
Autor:
Irina Lyakhova, Arina Ponomarenko, Maria Korneyko, S. Zaitsev, Igor Bryukhovetskiy, Yuri Khotimchenko, M. G. Eliseikina, Polina Mischenko, Yulia Zayats, Valeryi Shevchenko, Hari Shanker Sharma, Elena Milkina
Publikováno v:
Oncology Reports.
The majority of modern treatment methods for malignant brain tumors are not sufficiently effective, with a median survival time varying between 9 and 14 months. Metastatic and invasive processes are the principal characteristics of malignant tumors.
Autor:
Andrey Bryukhovetskiy, Yuri Khotimchenko, Polina Mischenko, Valeriy Shevchenko, Igor Bryukhovetskiy, Elena Milkina, Inessa V. Dyuizen
Publikováno v:
Molecular Medicine Reports
Glioblastoma multiforme is an aggressive malignant brain tumor with terminal consequences. A primary reason for its resistance to treatment is associated with cancer stem cells (CSCs), of which there are currently no effective ways to destroy. It rem
Autor:
Andrey Bryukhovetskiy, Elena Milkina, Igor Manzhulo, Inessa V. Dyuizen, Igor Bryukhovetskiy, Polina Mischenko, Yuri Khotimchenko
Publikováno v:
Oncology Letters
The development of antitumor medication based on autologous stem cells is one of the most advanced methods in glioblastoma multiforme (GBM) treatment. However, there are no objective criteria for evaluating the effectiveness of this medication on can